RLAY earnings date and last-quarter result: next report 2026-08-06, last quarter beat, P/E -12.27. Updated 2026-07-23.
Relay Therapeutics (RLAY) Research Hub
Relay Therapeutics (RLAY) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 18.12 USD (-0.33%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -12.27, market cap 3.37B. This hub links to the full technical, earnings and options research available for RLAY.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 18.12 USD (-0.33%) |
| 52-week range | 14.83 USD – 21.27 USD |
| Trend regime | Range |
| 14-day RSI | 45.3 (Neutral) |
| Trailing P/E | -12.27 |
| Market cap | 3.37B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-06 |
Available research for RLAY
Covered Call on RLAY: how it works, illustrative setup around the real 18.12 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on RLAY: how it works, illustrative setup around the real 18.12 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on RLAY: how it works, illustrative setup around the real 18.12 USD price, max profit/loss, breakeven and when to use it. Educational.
RLAY technical analysis: range, last 18.12 USD, RSI 45.3, 52w range 14.83 USD–21.27 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is RLAY in?
Relay Therapeutics (RLAY) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is RLAY in an uptrend or downtrend?
As of 2026-10-26, RLAY is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is RLAY's trailing P/E ratio?
RLAY's trailing P/E is -12.27, with a market cap of 3.37B. See the earnings research page for full valuation detail.
When does RLAY next report earnings?
RLAY is next scheduled to report earnings on 2026-08-06.